Abstract Submission Guide

Abstract Submission Dates

Abstracts must be submitted to imssc.scientificdesk@gmail.com until 21st of March 2022, 23.59 GMT+1.

Eligibility

  • Original researchs and case reports on any topic will be accepted.

  • The researchs and case reports must not be published before by someone else.

  • The abstracts must be original research or case reports.

  • The abstracts must not be rewarded in any international/national student congress before.

  • The abstracts must be authentic, understandable, educational, clinically interesting, and worthy of discussion, particularly around aspects of differential diagnosis, decision making, management, clinical guidelines and pathology.

  • Consent e-mail by the supervisor must be sent to us, otherwise your abstract will not be taken into consideration.

 

Content

Abstract layout- Abstracts should use the following structured format:

For Original Researches

  1. Title

  2. Authors

  3. Author affiliations

  4. Introduction

  5. Objectives

  6. Material & Method

  7. Results

  8. Conclusion

  9. Keywords

For an example of research articles, you can visit: 

 

For Case Reports

  1. Title

  2. Authors

  3. Author affiliations

  4. Introduction

  5. Material & Method (Please write your case presentation here)

  6. Discussion

  7. Conclusion

  8. Keywords

 

For Guidelines to Writing A Clinical Case Report, you can visit:

Abstract Title

  • A maximum of 200 characters typed in UPPER-CASE letters is permitted.

Abstract Authors

  • Only one of the authors can present the abstract.

  • Please underline the presenting author in the abstract.

  • Please enter all co-authors that were involved in the work of the abstract with their affiliation.

 

Abstract Text

  • Abstract text must be limited to 250 words for case presentation, 500 words for research.

  • All abstracts must be submitted (and presented) in English with accurate grammar and spelling suitable for publication.

  • Please do not add tables, graphs or images to the abstract.

  • Submissions must not contain patient names, hospital ID numbers or other identifying information.

  • Use generic names of drugs. The use of commercial drug names, brands, and registered trademarks is prohibited.

  • Limit the use of acronyms and abbreviations. Define at first use with acronym or abbreviation in parentheses.